Imagion Biosystems Limited
IBXXF
$0.01
-$0.025-71.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 335.60K | 345.10K | 538.70K | 537.60K | 1.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 335.60K | 345.10K | 538.70K | 537.60K | 1.39M |
| Cost of Revenue | 22.20K | 22.80K | 109.70K | 109.40K | 991.30K |
| Gross Profit | 313.40K | 322.30K | 429.10K | 428.20K | 403.60K |
| SG&A Expenses | 253.80K | 261.00K | 606.40K | 605.20K | 1.68M |
| Depreciation & Amortization | 2.50K | 2.60K | 126.60K | 126.40K | 195.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 278.60K | 286.50K | 842.70K | 841.00K | 2.87M |
| Operating Income | 57.00K | 58.60K | -304.00K | -303.40K | -1.47M |
| Income Before Tax | -176.00K | -181.00K | -503.10K | -502.00K | -1.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -176.00K | -181.00K | -503.10K | -502.00K | -1.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -176.00K | -181.00K | -503.10K | -502.00K | -1.56M |
| EBIT | 57.00K | 58.60K | -304.00K | -303.40K | -1.47M |
| EBITDA | 64.80K | 106.90K | -177.40K | -177.00K | -1.28M |
| EPS Basic | 0.00 | 0.00 | -0.02 | -0.02 | -0.05 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.03 |
| EPS Diluted | 0.00 | 0.00 | -0.02 | -0.02 | -0.05 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.03 |
| Average Basic Shares Outstanding | 57.27M | 57.27M | 32.62M | 32.62M | 32.72M |
| Average Diluted Shares Outstanding | 57.27M | 57.27M | 32.62M | 32.62M | 32.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
